What is Hemispheric?
Hemispheric operates as a specialized NeuroAI company dedicated to the development of foundational artificial intelligence capable of interpreting non-invasive brain activity. At the core of its technological stack is the Descartes model, which is trained on one of the world's most extensive proprietary multimodal brain datasets. This architecture allows the firm to translate intricate neural signals into actionable insights, serving a diverse array of high-growth sectors including precision brain health, brain-computer interfaces, and the development of CNS-focused medical devices and pharmaceuticals. By bridging the gap between raw neural data and clinical application, Hemispheric is effectively redefining the standards for non-invasive neurological diagnostics and therapeutic monitoring.
How much funding has Hemispheric raised?
Hemispheric has raised a total of $52M across 1 funding round:
Unspecified
$52M
Unspecified (2026): $52M with participation from Hanaco, Protocol Labs, One Mind, L Catterton, and Arkin Holdings
Key Investors in Hemispheric
Hanaco
Hanaco Ventures is a venture capital firm focused on supporting founders with big ideas and turning their visions into successful businesses through decisive action and collaboration.
Protocol Labs
Protocol Labs is a research, development, and deployment lab for network protocols that creates software systems to tackle significant technological challenges.
One Mind
One Mind is a leading mental health non-profit that catalyzes comprehensive action across the brain health crisis, working from science to patients to society.
What's next for Hemispheric?
With the successful closure of this major strategic investment, Hemispheric is poised to accelerate its product roadmap and expand its footprint in the global healthcare market. The company's immediate focus will likely center on the commercialization of the Descartes platform, specifically targeting partnerships with pharmaceutical firms and medical device manufacturers to integrate its neural decoding capabilities into existing clinical workflows. Furthermore, the firm is expected to invest heavily in data acquisition and model optimization to maintain its competitive edge in the NeuroAI space. As the demand for precision brain health solutions continues to rise, Hemispheric is well-positioned to leverage its unique data advantage to secure a leadership role in the future of human-computer interaction and neurological medicine.
See full Hemispheric company page
